While I see fully the benefits of social prescribing from the “patient” perspective - it comes from a person they likely trust and therefore more apt to listen, like nature prescribing in the UK - sadly, I’m realistic bordering on pessimistic that nothing will change without payment to the “prescriber”. Have you see any innovations come out of the payment side of the equation?
Great question - and the short answer is - sort of. I know Art Pharmacy is actively working with payors to see if they would be willing to support this type of work. But you are on to a bigger issue, which is how we can get payors to begin to pay for things outside of clinics - they do that a little bit, but this feels like a stretch for them (for now). All we can do is keep pushing!
This makes sense on many levels!
While I see fully the benefits of social prescribing from the “patient” perspective - it comes from a person they likely trust and therefore more apt to listen, like nature prescribing in the UK - sadly, I’m realistic bordering on pessimistic that nothing will change without payment to the “prescriber”. Have you see any innovations come out of the payment side of the equation?
Great question - and the short answer is - sort of. I know Art Pharmacy is actively working with payors to see if they would be willing to support this type of work. But you are on to a bigger issue, which is how we can get payors to begin to pay for things outside of clinics - they do that a little bit, but this feels like a stretch for them (for now). All we can do is keep pushing!